NoileImmune is a cutting-edge biotech company focused on cancer immunotherapy. As a venture originating from a national cancer research center, we strive to become a leading company in the field of cancer immunotherapy, specializing in CAR-T cell therapy. Our goal is to create the future of cancer treatment through the development of innovative and effective immunotherapeutic approaches.

At NoileImmune, our prime focus is on developing CAR-T cell therapies. We leverage our versatile and scalable Noile technology to optimize the functionality of CAR-T cells, making them more effective in fighting cancer. Our commitment to advancing the frontier of cancer treatment is evident in our partnership with Sysmex, a leader in the field of diagnostic technologies, to enhance the optimization of CAR-T cell functions.

With a strong leadership team and dedication to scientific excellence, we are poised to revolutionize cancer treatment. Join us on our mission to overcome cancer and create a brighter future for patients worldwide